Cofoe Medical Technology (301087.SZ) plans to acquire a 60% stake in Kangjuren for RMB99.48 million to improve its respiratory support segment layout.

date
20:00 19/11/2026
avatar
GMT Eight
Cofoe Medical Technology (301087.SZ) announced that the company plans to acquire a 60% equity stake in Hefei Kangjuren Medical Device Technology Co., Ltd. ("Kangjuren") for RMB99.48 million using its own funds. Upon completion of the transaction, Kangjuren will become a controlled subsidiary of the company and will be included in the company's consolidated financial statements. The target company is engaged in the research and development, production, sales, and service of medical devices such as oxygen concentrators and nebulizers.
Cofoe Medical Technology (301087.SZ) announced that the company plans to acquire a 60% equity stake in Hefei Kangjuren Medical Device Technology Co., Ltd. ("Kangjuren") for RMB99.48 million using its own funds. Upon completion of the transaction, Kangjuren will become a controlled subsidiary of the company and will be consolidated into the company's financial statements. The target company is engaged in the R&D, production, sales, and service of medical devices such as oxygen concentrators and nebulizers. The acquisition of a 60% equity stake in the target company will help the company improve its respiratory support segment layout, positively assist the company in expanding its market share in oxygen concentrators and consolidating its market position in the respiratory health field, and effectively expand the production capacity of the company's oxygen concentrator product line. The target company's business is primarily focused on online channels and ODM business. The company can leverage its own brand influence, Wuxi Online Offline Communication Information Technology Co., Ltd.'s integrated channels, and overseas sales network to improve the target company's product structure and profitability.